These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6098328)

  • 41. Modulation of CNS dopamine receptors by peptides.
    Mishra RK
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):437-42. PubMed ID: 6141599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.
    Tam SW; Cook L
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5618-21. PubMed ID: 6147851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of morphine analgesia after acute and chronic haloperidol.
    Head M; Lal H; Puri S; Mantione C; Valentino D
    Life Sci; 1979 May; 24(22):2037-43. PubMed ID: 222988
    [No Abstract]   [Full Text] [Related]  

  • 44. Ascorbic acid reduces accumulation of [3H]spiperone in mouse striatum in vivo.
    Dorris RL
    Proc Soc Exp Biol Med; 1987 Oct; 186(1):13-6. PubMed ID: 3628250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density.
    Prasad C; Spahn SA; Ikegami H
    Biochem Biophys Res Commun; 1989 Feb; 159(1):48-52. PubMed ID: 2522303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of duration of haloperidol treatment on DA receptor supersensitization in aging C57BL/6J mice.
    Randall PK; Severson JA; Hurd SM; McClure WO
    Brain Res; 1985 Apr; 333(1):85-95. PubMed ID: 4039618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG).
    Rajakumar G; Naas F; Johnson RL; Chiu S; Yu KL; Mishra RK
    Peptides; 1987; 8(5):855-61. PubMed ID: 2893360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
    Janowsky A; Neve KA; Kinzie JM; Taylor B; de Paulis T; Belknap JK
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine binding following prolonged haloperidol pretreatment.
    Hitri A; Weiner WJ; Borison RL; Diamond BI; Nausieda PA; Klawans HL
    Ann Neurol; 1978 Feb; 3(2):134-40. PubMed ID: 655662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of chronic treatment with haloperidol on serum prolactin, striatal opiate receptors and beta-endorphin content in rat brain and pituitary.
    Kato N; Shah KR; Friesen HG; Havlicek V
    Prog Neuropsychopharmacol; 1981; 5(5-6):549-52. PubMed ID: 6280225
    [No Abstract]   [Full Text] [Related]  

  • 52. Psychomotor performance in the senescent rodent: reduction of deficits via striatal dopamine receptor up-regulation.
    Joseph JA; Bartus RT; Clody D; Morgan D; Finch C; Beer B; Sesack S
    Neurobiol Aging; 1983; 4(4):313-9. PubMed ID: 6687001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of acrylamide given during gestation on dopamine receptor binding in rat pups.
    Agrawal AK; Squibb RE
    Toxicol Lett; 1981 Jan; 7(3):233-8. PubMed ID: 7222099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain.
    Reches A; Wagner HR; Jiang D; Jackson V; Fahn S
    Life Sci; 1982 Jul; 31(1):37-44. PubMed ID: 7109853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors.
    Di Paolo T; Poyet P; Labrie F
    Eur J Pharmacol; 1981 Jul; 73(1):105-6. PubMed ID: 7198580
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term application of haloperidol: effects on dopamine and acetylcholine receptors.
    Stock G; Kummer P
    Int Pharmacopsychiatry; 1981; 16(3):144-53. PubMed ID: 6797983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of dopamine receptor ligands with subtypes of the opiate receptor.
    Boublik JH; Funder JW
    Eur J Pharmacol; 1984 Dec; 107(1):11-6. PubMed ID: 6098481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired striatal dopamine receptor development: differential D-1 regulation in adults.
    Saleh MI; Kostrzewa RM
    Eur J Pharmacol; 1988 Sep; 154(3):305-11. PubMed ID: 3069481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of lithium and sodium ions on opiate- and dopamine-receptor binding.
    Wajda IJ; Banay-Schwartz M; Manigault I; Lajtha A
    Neurochem Res; 1981 Mar; 6(3):321-31. PubMed ID: 6269012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings.
    Chiu S; Paulose CS; Mishra RK
    Peptides; 1981; 2(1):105-11. PubMed ID: 6113579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.